A licensee may use any unsealed radioactive material prepared for medical use and for which a written directive is required that is:
obtained from a manufacturer or preparer licensed under part 4731.3395 or equivalent requirements of the NRC or an agreement state or a PET radioactive drug producer licensed according to part 4731.3065, subpart 7, or equivalent requirements of the NRC or an agreement state;
excluding production of PET radionuclides, prepared by an authorized nuclear pharmacist, a physician who is an authorized user and meets the requirements under part 4731.4436 or 4731.4443, or an individual under the supervision of either, as specified under part 4731.4407;
obtained from and prepared by a commissioner, NRC, or agreement state licensee for use in research according to an investigational new drug protocol accepted by the Food and Drug Administration; or
prepared by the licensee for use in research according to an investigational new drug protocol accepted by the Food and Drug Administration.
29 SR 755; 33 SR 1440
March 12, 2009
Official Publication of the State of Minnesota
Revisor of Statutes